provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeHealth ConditionsAllergies

What Is DRESS Syndrome and What Causes It?

Valerie Hanft, MDJoshua Murdock, PharmD, BCBBS
Published on September 13, 2021

Key takeaways:

  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a rare and potentially life-threatening reaction to a medication.

  • Fever, rash, and internal organ involvement are the hallmark features of this condition.

  • With early diagnosis and treatment, most people recover completely, but some may have permanent organ damage or develop an autoimmune disease after DRESS syndrome symptoms resolve.

Nurse holding a thermometer and talking to a patient who is in bed.
visualspace/E+ via Getty Images

Hives, rashes, and trouble breathing are all potential signs of an allergic reaction. One potential trigger for allergic reactions is starting a new medication. In very rare cases, medication allergies can be dangerous or life-threatening.

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is one example of a serious medication allergy. It’s a type of severe allergic reaction to a medication that occurs anywhere from 2 to 8 weeks after starting a medication. DRESS syndrome is characterized by fever, rash, abnormal blood tests, and swollen lymph nodes (small glands that filter foreign substances and contain cells that help the body fight infection). The condition also affects at least one internal organ — most often the liver.

DRESS syndrome is rare — estimated to affect between 1 in 1,000 to 1 in 10,000 people exposed to a medication. However, it’s a life-threatening condition with about a 10% mortality rate — meaning 10% of those who develop it die.

Search and compare options

Search is powered by a third party. By clicking a topic in the advertisement above, you agree that you will visit a landing page with search results generated by a third party, and that your personal identifiers and engagement on this page and the landing page may be shared with such third party. GoodRx may receive compensation in relation to your search.

Below, we’ll discuss medications that are closely linked with DRESS syndrome, potential signs of this condition, and people who may have a greater chance of developing this severe allergic reaction.

What causes DRESS syndrome? 

The precise cause of DRESS syndrome isn’t well understood, but it’s thought that some cases may be caused by a defect in the way the liver metabolizes (breaks down) certain medications. Reactivation of a virus — when a virus that is inactive (dormant) in your body becomes active again — may also play a role by triggering the immune system to overreact.

The viruses typically associated with DRESS syndrome are human herpesvirus 6 (HHV-6, a virus that causes roseola), human herpesvirus 7 (HHV-7, another cause of roseola), and human herpesvirus 4 (HHV-4 or Epstein-Barr virus, the virus that causes mononucleosis).

Many people may have had one or more of these infections during childhood or early adulthood. They often remain dormant for a lifetime, causing no problems. It’s unclear why these viruses become active again for some people.

What medications can cause DRESS syndrome?

There’s a delay between the moment a person starts a medication and when DRESS syndrome symptoms begin. This is quite different from many common medication reactions, which often occur within hours or days of taking a medication. With DRESS syndrome, the reaction can occur anywhere between 2 to 8 weeks after starting a medication and continue even after stopping it.

The medications most frequently associated with DRESS syndrome are:

This isn’t an all-inclusive list of medications that can cause DRESS syndrome. Please speak with your healthcare provider or pharmacist to ask if any of your medications are known to cause this condition.

Is DRESS syndrome a medical emergency?

Yes. People with this condition may require a hospital stay to manage and treat the condition. An intensive care unit (ICU) setting may also be necessary because DRESS syndrome can seriously affect internal organs. 

Because DRESS syndrome is fatal for about 10% of those who develop it, early diagnosis and treatment are essential. A delay in treatment could have grave consequences.

What are the symptoms of DRESS syndrome?

There isn’t one test that can confirm if a person has DRESS syndrome. Rather, healthcare providers use criteria to help them diagnose the condition.

These criteria state that at least three of the following should be present to consider a DRESS syndrome diagnosis:

  • A person is in the hospital

  • A fever greater than 100.4℉ (38℃)

  • A sudden rash develops — usually redness involving the entire body, followed by peeling

  • Enlarged lymph nodes in at least two different areas of the body

  • Problems with at least one internal organ, such as the liver, thyroid, kidney, lung, or heart

  • Abnormal blood levels of lymphocytes (a type of white blood cell), eosinophils (another type of white blood cell), or platelets (a blood component necessary for forming blood clots)

  • Suspicion that these symptoms may be related to a medication

Most of these criteria would be discovered by a healthcare provider, but there are two you can watch for at home. If you ever develop a sudden, severe rash along with a fever, seek medical attention right away.

How do you treat DRESS syndrome?

First, it’s crucial to stop the triggering medication. This can pose a challenge if the person takes multiple medications. Be sure to give your healthcare provider a complete list of all medications — including over-the-counter and herbal products.

Because internal organs — such as the liver, kidney, heart, and lung — are often affected, almost all people affected will need supportive care in an ICU or a burn unit setting. Supportive care can include dialysis for kidney problems and medications to help relieve heart, lung, and thyroid symptoms.

Oral or intravenous (IV) corticosteroids — such as prednisone or methylprednisolone — are often given to calm down the immune system’s reaction and prevent organ damage. Typically, oral steroid doses are slowly decreased over a period of 6 to 8 weeks after the initial treatment is complete. Corticosteroid creams can help control rash symptoms.

Antiviral medications may be useful in some cases — such as when DRESS syndrome is thought to be linked to virus reactivation. Ganciclovir (Cytovene) is the antiviral medication that’s been most studied for treating DRESS syndrome.

What is the outlook for someone with DRESS syndrome?

As previously mentioned, approximately 10% of people with DRESS syndrome don’t survive. But, with prompt diagnosis and removal of the triggering medication, most people will recover completely.

Even so, long-term problems due to DRESS syndrome are still possible. A small study showed complications occurred in roughly 11% of people who developed the condition. Younger people in the study were more likely to develop autoimmune diseases, such as type 1 diabetes or Graves’ disease (an autoimmune thyroid condition). Older study participants were more vulnerable to permanent organ damage such as kidney failure. 

Other long-term complications include lupus, alopecia areata (a condition that causes hair loss), and vitiligo (a condition where patches of skin lose their color). The reasoning for these long-term problems isn’t fully understood.

What factors raise your risk of getting DRESS syndrome?

While risk factors still aren’t completely understood, certain genetic traits or changes may raise the risk of a person developing DRESS syndrome. Some genes play a role in how certain medications are metabolized in the body. If the body isn’t breaking down medications properly, there is concern DRESS syndrome could occur.

Rapidly raising the dose when first starting certain medications may also be linked to DRESS syndrome. The anti-seizure medications lamotrigine and carbamazepine have boxed warnings (the FDA’s strictest medication warning), which state that this condition has been reported in people who started with higher doses than what’s recommended.

Two of the viruses associated with DRESS syndrome — HHV-6 and -7 — are common infections that usually become inactive after the initial infection resolves. However, people with DRESS syndrome who test positive for reactivation of these viruses tend to have longer hospital stays and worse outcomes.

What can you do to lower your chances of getting DRESS syndrome?

If anyone in your family has experienced DRESS syndrome, speak with your healthcare provider. As discussed above, there are some genetic markers that may raise your chance of developing a reaction to certain medications. Your healthcare provider may be able to screen you for these genetic markers and advise you if you should be cautious with certain medications.

If you’re prescribed a medication where the dose is raised slowly in the beginning, this is most likely done to lower your risk of complications, quite possibly for DRESS syndrome. Be sure to follow your healthcare provider’s instructions carefully, and always double check with them if you are unsure of your dose.

The bottom line

DRESS syndrome is a rare medication-related reaction characterized by a fever, rash, and affects one or more internal organs. Treatment involves stopping the triggering medication, hospitalization with supportive care for the organs affected, and corticosteroid medications. The majority of people who develop DRESS syndrome will fully recover, but some may experience long-term problems, including autoimmune diseases or permanent organ damage. If you believe you could be experiencing DRESS syndrome, seek medical attention right away.

why trust our exports reliability shield

Why trust our experts?

Valerie Hanft, MD
Valerie Hanft, MD, has practiced general medical and pediatric dermatology for 20 years. She has served on the FDA Task Force, participated in many clinical trials, and authored multiple peer-reviewed publications.
Christina Aungst, PharmD
Christina Aungst, PharmD, is a pharmacy editor for GoodRx. She began writing for GoodRx Health in 2019, transitioning from freelance writer to editor in 2021.
Joshua Murdock, PharmD, BCBBS
Joshua Murdock, PharmD, BCBBS, is a licensed pharmacist in Arizona, Colorado, and Rhode Island. He has worked in the pharmacy industry for more than 10 years and currently serves as a pharmacy editor for GoodRx.

References

American Academy of Allergy, Asthma & Immunology. (2020). Medications and drug allergic reactions.

American Academy of Dermatology Association. (n.d.). Hair loss types: Alopecia areata overview.

View All References (26)

American Osteopathic College of Dermatology. (n.d.). Vitiligo.

Asthma and Allergy Foundation of America. (2015). Drug allergy and other adverse reactions to drugs.

Asthma and Allergy Foundation of America. (2015). What are the symptoms of an allergy?

Aurobindo Pharma Limited. (2021). Lamotrigine [package insert]

Cacoub, P., et al. (2011). The DRESS syndrome: A literature review. The American Journal of Medicine.

Centers for Disease Control and Prevention. (2020). About Epstein-Barr virus (EBV).

Chen, Y. C., et al. (2012). Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan. Journal of the American Academy of Dermatology.

Cho, Y. T., et al. (2017). Drug reaction with eosinophilia and systemic symptoms (DRESS): An interplay among drugs, viruses, and immune system. International Journal of Molecular Sciences.

Choudhary, S., et al. (2013). Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. The Journal of Clinical and Aesthetic Dermatology.

De, A., et al. (2018). Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature. Indian Journal of Dermatology.

Descamps, V. (2013). Diagnosis of DRESS (drug reaction with eosinophilia and systemic symptoms) in the intensive care unit: Essential but challenging. Shock.

Eshki, M., et al. (2009). Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: A cause of unpredictable multiorgan failure. JAMA Dermatology.

Grinde, B. (2013). Herpesviruses: Latency and reactivation – Viral strategies and host response. Journal of Oral Microbiology.

HHV-6 Foundation. (n.d.). What is HHV-6?

Husain, Z., et al. (2013). DRESS syndrome: Part II. Management and therapeutics. Journal of the American Academy of Dermatology.

Le, J. (2020). Drug metabolism. Merck Manual.

Marshall, J. C., et al. (2017). What is an intensive care unit? A report of the task force of the World Federation of Societies of Intensive and Critical Care Medicine. Journal of Critical Care.

MedlinePlus. (2022). Roseola.

National Cancer Institute. (n.d.). Lymph node.

National Institute of Diabetes and Digestive and Kidney Diseases. (2021). Graves’ disease.

Pritchett, J. C., et al. (2012). The link between hypersensitivity syndrome reaction development and human herpes virus-6 reactivation. International Journal of Hepatology.

RemedyRepack, Inc. (2021). Carbamazepine [package insert]

ScienceDirect. (2012). Human herpesvirus 7.

The RegiSCAR Project. (n.d.). HSS/DRESS.

U.S. Food and Drug Administration. (2012). A guide to drug safety terms at FDA.

Zhang, J., et al. (2021). Current perspectives on severe drug eruption. Clinical Reviews in Allergy & Immunology.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Let's Help You Breathe Better!

Sign up for our GoodRx Health Asthma and Allergies Newsletter to receive up-to-date information on the latest medications, treatments, and savings that are most relevant to you.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

Related Articles